 |
|
Prenatal Drug Use in Minneapolis^St Paul, MinnA 4-Year Trend
Barbara P. Yawn, MD, MS;
Linda R. Thompson, MD;
Virginia R. Lupo, MD;
Mary Kay Googins, MSCT;
Roy A. Yawn, MD
Arch Fam Med. 1994;3(6):520-527.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Bandstra ES. Substance abuse in the perinatal period. Semin Perinatol. 1991;15:65-331.
PUBMED
2. Benowitz NL. Nicotine replacement therapy during pregnancy. JAMA. 1991;266:3174-3177.
FREE FULL TEXT
3. Butler NR, Goldstein H, Ross EM. Cigarette smoking in pregnancy: its influence on birth weight and perinatal mortality. BMJ. 1972;2:127-130.
FREE FULL TEXT
4. Chasnoff IJ, Burns WJ, Scholl SH, et al. Cocaine use in pregnancy. N Engl J Med. 1985;313:666-669.
PUBMED
5. Chasnoff IJ, Burns KA, Burns WJ, et al. Prenatal drug exposure: effects on neonatal and infant growth and development. Neurobehav Toxicol Teratol. 1986;8:357-362.
PUBMED
6. Chasnoff IJ, Chisum GM, Kaplan WE. Maternal cocaine use and genitourinary tract malformations. Teratology. 1988;37:201-204.
PUBMED
7. Centers for Disease Control. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. Rockville, Md: US Dept of Health and Human Services, Public Health Service Division; 1989. US Dept of Health and Human Services publication CDC 89-8411. 8. Choteau M, Namerow PB, Leppert PL. The effect of cocaine abuse on birth weight and gestational age. Obstet Gynecol. 1988;72:351-354.
PUBMED
9. Dahl RE, Scher MS, Day NL, et al. The effects of prenatal marijuana exposure: evidence of EEG sleep disturbances. J Dev Behav Pediatr. 1989;10:264-266.
PUBMED
10. Dixon SD, Bejar R. Brain lesions in cocaine and methamphetamine exposed neonates. Pediatr Res. 1988;23:405A.
11. Dombowski MP, Wolfe HM, Welch RA, et al. Cocaine does not shorten labor but decreases birthweight and increases the incidence of abruptio placentae. Presented at the Tenth Annual Meeting of the Society of Perinatal Obstetricians; March 1990; Houston, Tex. 12. Eriksson M, Larsson G, Zetterstrom R. Amphetamine addiction an pregnancy. Acta Obstet Gynecol Scand. 1981;60:253-259.
PUBMED
13. Fried PA, Watkinson B, Willan A. Marijuana use during pregnancy and decreased length of gestation. Am J Obstet Gynecol. 1984;150:23-27.
PUBMED
14. Fried PA, O'Connell CM. A comparison of the effects of prenatal exposure to tobacco, alcohol, cannabis and caffeine on birth size and subsequent growth. Neurotoxicol Teratol. 1987;9:79-85.
PUBMED
15. Fried PA, Watkinson B. 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes and alcohol. J Dev Behav Pediatr. 1990;11:49-58.
PUBMED
16. Fried PA. Marijuana use during pregnancy: consequences for the offspring. Semin Perinatol. 1991;15:280-287.
PUBMED
17. Frier MC, Griffith Dr, Chasnoff IJ. In utero drug exposure: developmental follow-up and maternal-infant interaction Semin Perinatol. 1991;15:310-316.
18. Gillogley KM, Evans AT, Hasen R, et al. The perinatal impact of maternal substance abuse detected by universla intrapartum screening. Am J Obstet Gynecol. 1990;163:1535-1542.
PUBMED
19. Hayford SM, Epps RP, Dahl-Regis M. Behavior and development patterns in children born to heroin addicted and methadone mothers. J Natl Med Assoc. 1988;80:1197-1200.
PUBMED
20. Hatch EE, Bracken MB. Effects of marijuana use in pregnancy on fetal outcome. Am J Epidemiol. 1986;124:986.
FREE FULL TEXT
21. Hoyme HE, Higginbottom MC, Jones KL. Vascular pathogenesis of transverse limb reduction defects. J Pediatr. 1982;101:839-843.
PUBMED
22. Kline J, Stein Z, Hutzler M. Cigarettes, alcohol and marijuana: varying associations with birth weight. Int J Epidemiol. 1987;16:44-51.
FREE FULL TEXT
23. Linn S, Schoenbaum S, Monson R, et al. The association of marijuana uae with outcome of pregnancy. Am J Public Health. 1983;73:1161-1164.
PUBMED
24. Neerhof MF, Mc Gregor SN, Retzky SS, et al. Cocaine abuse during pregnancy: peripartum pervalence and perinatal outcome. Am J Obstet Gynecol. 1989;616:688-691.
25. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr. 1987;111:571-578.
PUBMED
26. Pelosi MA, Frattarola M, Apuzzio J, al. Pregnancy complicated by heroin addiction. Obstet Gynecol. 1975;45:512-515.
PUBMED
27. Toubas PL, Duke JC, MaCaffree MA. Effects of maternal smoking and caffeine habits on infatile apnea: a retrospective study. Pediatrics. 1986;78:159-163.
FREE FULL TEXT
28. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuama and cocaine use on fetal growth. N Engl J Med. 1989;320:762-768.
PUBMED
29. Vega WA, Kolody B, Hwang J, Noble A. Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med. 1993;329:850-854.
PUBMED
30. Chasnoff IJ, Landress HF, Barrett ME. The pervalence of illicit drug or alcohol use during pregnancy and discrepancies in mandatory repoting in Pinellas County, Florida. N Engl J Med. 1990;322:1202-1206.
PUBMED
31. Ostrea EM Jr, Brady M, Gause S, Raymundo AL, Stevens M. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics. 1992;89:107-113.
FREE FULL TEXT
32. Evans AT, Gillogley K. Drug use in pregnancy: obstetric perspectives. Clin Perinatol. 1991;18:23-32.
PUBMED
33. Lupo V, Uden DL, Yawn BP. Drug use in metropolitan pregannt women: Minneapolis and St Paul. Minn Med. In press. 34. Hurt H. 1000 babies: Philadephia 1989. Pediatr Res. 1990;27:93A. Abstract.
35. Centers for Disease Control. Statewide prevalence of illicit drug use by pregant women^Rhode Island. MMWR Morb Mortal Wkly Rep. 1990;35:225-227.
36. McCalla S, Minkoff HL, Feldman J, et al. The biologic and socila consequences of perinatal cocaine use in an inner-city population: results of an anonymous cross-sectional study. Am J Obstet Gynecol. 1991;164:625-630.
PUBMED
37. Schutzman DL, Frankenfield-Chernicoff M, Clatterbaugh HE, Singer J. Incidece of intrauterine cocaine exposure in a suburban setting. Pediatrics 1991;88:825-827.
FREE FULL TEXT
39. Moser JM, Jones VH, Kuthy ML. Use of cocaine during the immeduate prepartum period by childbearing women in Ohio. Am J Prev Med. 1993;9:85-91.
PUBMED
40. Rosengren SS, Longobucco DB, Bernstein BA, et al. Meconium testing for cocaine metabolite: prevalence, perceptions, and pitfalls. J Obstet Gynecol. 1993;168:1449-1456.
41. Buchi KF, Varner MW, Chase RA. The prevalence of substance abuse among pregnant women in Utah. Obstet Gynecol. 1993;81:239-242.
PUBMED
42. Burke MS, Roth D. Anonymonus cocaine screening in a private obstetrc population. Obstet Gynecol. 1993;81:354-356.
PUBMED
43. Yawn BP, Yawn RA, Uden DL. Substance use in rural midwestern women. Arch Fam Med. 1992;1:83-88.
FREE FULL TEXT
44. Ostrea EM Jr, Welch RA. Detection of prenatal durg exposure in the pregnant woman and her newborn infant. Clin Perinatol. 1991;18:629-645.
PUBMED
45. Centers for Disease Control. Prevalence of High Risk Behaviors. National Health Behavior Survey. Atlanta, Ga: CDC; 1990. 46. McCalla S, Minkoff HL, Feldman J, Glass L, Valencia G. Predictors of cocaine use in pregnancy. Obstet Gynecol. 1992;79:641-644.
PUBMED
47. Falkowski C. Trends of Illicit Drug Use in Minnesota, 1993. St Paul: Minnesota Dept of Health, Chemical Dependency Program Division; 1993. 48. Maynard EC, Amoruso LP, Oh W. Meconium for durg testing. AJDC. 1991;145:650-652.
PUBMED
49. Ostrea EM Jr, Romero A, Yee H. Adaptation of the meconium durg test for mass screening. J Pediatr. 1993;122:152-154.
PUBMED
50. Castro LC, Azen C, Hobel CJ, Platt LD. Maternal tobacco use and substance abuse: reported prevalence rates and associations with the delivery of small for gestational age neonates. Obstet Gynecol. 1993;81:396-401.
PUBMED
|
